BioCentury
ARTICLE | Clinical News

Savvy glyminox: Began Phase I testing

May 3, 1999 7:00 AM UTC

Biosyn Inc., Philadelphia, Penn. Product: Savvy glyminox Therapeutic category: Viral infection Target: Cell membranes of pathogens Description: Vaginal gel formulation of the antimicrobial agent glymi...